Systematic review and network meta-analysis of performance of the Sapporo criteria, the Revised Sapporo criteria, and the 2023 ACR/EULAR APS classification criteria for patients with antiphospholipid syndrome: A protocol
Jie Wang, Yangqi Yin, Jiaqi Qu, Zhongbin Tao, Xuyang Chi, Xinyue Zhang · 2026
Read Systematic review and network meta-analysis of performance of the Sapporo criteria, the Revised Sapporo criteria, and the 2023 ACR/EULAR APS classification criteria for patients with antiphospholipid syndrome: A protocol by Jie Wang, Yangqi Yin, Jiaqi Qu, Zhongbin Tao, Xuyang Chi, Xinyue Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0359310.txt.
Description
Jie Wang and co-authors set out a protocol in 2026 for comparing three sets of criteria used to classify antiphospholipid syndrome. This autoimmune condition makes blood more likely to clot and complicates pregnancies, and classifying it consistently is essential for research. The planned study is a systematic review with network meta-analysis, a method for comparing several options across many studies at once.
The criteria under comparison are the Sapporo criteria, their revised version, and the newer 2023 criteria from two major rheumatology bodies. The protocol fixes the questions and methods in advance, so the eventual results can be judged against a public plan. Which set performs best shapes who counts as a patient in every future trial of this disease.
Catalog record
| CREATOR | Jie Wang, Yangqi Yin, Jiaqi Qu, Zhongbin Tao, Xuyang Chi, Xinyue Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24187 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |